Trans* people’s access to gender-affirming health care: A European comparison
Breckenkamp J, Thirugnanamohan J, Stern AW, Razum O, Namer Y (2022)
European Journal of Public Health 32(Supplement_3): ckac129.070.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Einrichtung
Abstract / Bemerkung
Trans* people's life satisfaction is correlated with established legal frameworks for gender recognition and access to trans*-specific health care (Transgender Europe [TGEU], 2021). TGEU's guidelines to human rights-based principles of trans*-specific health care highlight bodily integrity/autonomy, free self-determination of gender, quality, specialized and decentralized care, and the right to determine reproductive paths as important pillars of gender affirming health care. We conducted a policy comparison across Europe regarding access to gender-affirming health care to assess how adherence to human rights-based principles could be strengthened.
**Methods**
We compared access to health care across four main domains: legal framework (e.g., legally recognised genders), insurance coverage (e.g., out of pocket costs), access barriers (e.g., legal requirements to access gender-affirming surgery), and health care offers (e.g., hormone replacement therapy). Criteria were developed in guided brainstorming sessions. Three researchers rated 28 countries across 28 items based on available policy documents. **Results**
The majority of European countries prescribes a medicalised gender-affirming process rather than a self-decided process. Psychiatric diagnosis is also required in most countries to access gender-affirming health care. Gender-affirming health care is partly financed by statutory health insurance in most of the countries. Not all countries authorise full gender-affirming health care. Especially where statutory health insurance-covered gender-affirming health care relied centralised on single outpatient clinics or hospitals, waiting times between 6-24 months are found. **Conclusions**
Many European countries fail to fully comply with TGEU's guidelines to human rights-based principles of trans* health care. Given the negative impact of access barriers on life satisfaction, European countries should target these shortfalls in ensuring gender-affirming health care. **Key messages**
• Non- or only partly covered trans* health care contributes to health inequality. • Regarding trans* people, European countries need to strengthen human-rights based access to gender-affirming health care.
We compared access to health care across four main domains: legal framework (e.g., legally recognised genders), insurance coverage (e.g., out of pocket costs), access barriers (e.g., legal requirements to access gender-affirming surgery), and health care offers (e.g., hormone replacement therapy). Criteria were developed in guided brainstorming sessions. Three researchers rated 28 countries across 28 items based on available policy documents. **Results**
The majority of European countries prescribes a medicalised gender-affirming process rather than a self-decided process. Psychiatric diagnosis is also required in most countries to access gender-affirming health care. Gender-affirming health care is partly financed by statutory health insurance in most of the countries. Not all countries authorise full gender-affirming health care. Especially where statutory health insurance-covered gender-affirming health care relied centralised on single outpatient clinics or hospitals, waiting times between 6-24 months are found. **Conclusions**
Many European countries fail to fully comply with TGEU's guidelines to human rights-based principles of trans* health care. Given the negative impact of access barriers on life satisfaction, European countries should target these shortfalls in ensuring gender-affirming health care. **Key messages**
• Non- or only partly covered trans* health care contributes to health inequality. • Regarding trans* people, European countries need to strengthen human-rights based access to gender-affirming health care.
Erscheinungsjahr
2022
Serien- oder Zeitschriftentitel
European Journal of Public Health
Band
32
Ausgabe
Supplement_3
Art.-Nr.
ckac129.070
Urheberrecht / Lizenzen
ISSN
1101-1262
eISSN
1464-360X
Page URI
https://pub.uni-bielefeld.de/record/2967017
Zitieren
Breckenkamp J, Thirugnanamohan J, Stern AW, Razum O, Namer Y. Trans* people’s access to gender-affirming health care: A European comparison. European Journal of Public Health. 2022;32(Supplement_3): ckac129.070.
Breckenkamp, J., Thirugnanamohan, J., Stern, A. W., Razum, O., & Namer, Y. (2022). Trans* people’s access to gender-affirming health care: A European comparison. European Journal of Public Health, 32(Supplement_3), ckac129.070. https://doi.org/10.1093/eurpub/ckac129.070
Breckenkamp, Jürgen, Thirugnanamohan, Janiththa, Stern, Alex Willem, Razum, Oliver, and Namer, Yudit. 2022. “Trans* people’s access to gender-affirming health care: A European comparison”, European Journal of Public Health, 32 (Supplement_3): ckac129.070.
Breckenkamp, J., Thirugnanamohan, J., Stern, A. W., Razum, O., and Namer, Y. (2022). Trans* people’s access to gender-affirming health care: A European comparison. European Journal of Public Health 32:ckac129.070.
Breckenkamp, J., et al., 2022. Trans* people’s access to gender-affirming health care: A European comparison. European Journal of Public Health, 32(Supplement_3): ckac129.070.
J. Breckenkamp, et al., “Trans* people’s access to gender-affirming health care: A European comparison”, European Journal of Public Health, vol. 32, 2022, : ckac129.070.
Breckenkamp, J., Thirugnanamohan, J., Stern, A.W., Razum, O., Namer, Y.: Trans* people’s access to gender-affirming health care: A European comparison. European Journal of Public Health. 32, : ckac129.070 (2022).
Breckenkamp, Jürgen, Thirugnanamohan, Janiththa, Stern, Alex Willem, Razum, Oliver, and Namer, Yudit. “Trans* people’s access to gender-affirming health care: A European comparison”. European Journal of Public Health 32.Supplement_3 (2022): ckac129.070.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in